Skip to content
AFFIRMA BIOTECH SL logo — Affirma Biotech develops new products to overcome the challe...

AFFIRMA BIOTECH SL

Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections

Founded 2020 Spain Spain 5 employees Venture round Total: $1.98M Biopharma, Biotechnology +2

General Information

Company Name AFFIRMA BIOTECH SL
Founded Year 2020
Location Spain Spain
Employees 5
Industries Biopharma, Biotechnology, Life Sciences +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with AFFIRMA BIOTECH SL. To contact AFFIRMA BIOTECH SL, visit affirmabio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AFFIRMA BIOTECH SL compare?

A PDF of AFFIRMA BIOTECH SL and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AFFIRMA BIOTECH SL soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AFFIRMA BIOTECH SL

AFFIRMA BIOTECH SL

Slogan: Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections

Description: Affirma Biotech is a start-up company specialized in the discovery and development of new anti-infective drugs via immunomodulation.

Founded: 2020

Industries: Biopharma, Biotechnology, Pharmaceutical

Headquarter: Spain

Last Investment: €1.73M Venture Round investment at 01 February 2024

Last Investment Investors: Nara Capital, SeedBlink, Reig Jofre, GENESIS Biomed, Alfons Hidalgo, Capital Cell, BCN PEPTIDES

Overall, Affirma Biotech, founded in 2020 and headquartered in Spain, is focused on developing new anti-infective drugs to address Multi Drug Resistant and Chronic Infections. The company recently secured a venture round investment of €1.73M from a group of notable investors including Nara Capital, SeedBlink, Reig Jofre, GENESIS Biomed, Alfons Hidalgo, Capital Cell, and BCN PEPTIDES. With its specialization in immunomodulation, Affirma Biotech holds promise in bringing innovative solutions to the field of biopharma, biotechnology, and pharmaceuticals.

Business keywords: Drug development, Anti-infective drugs, Immunomodulation, Host-directed therapy, Host cell factors, Pathogen, Infectious diseases, Chronic infections, Multi Drug Resistant, Start-up company, Research and development, Pharmaceuticals, Biomedical innovation, Healthcare advancements

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €250.00K 1
Centre for the Development of Industrial Technology (CDTI)
01 Feb 2024
Venture Round €1.73M 7
Nara Capital, SeedBlink +5
01 Feb 2024

AFFIRMA BIOTECH SL Alternatives & Competitors

View All Alternatives
AFFIRMA BIOTECH SL vs

At DevsHealth, we leverage our advanced DeepTech platform to enhance the development of anti-infecti...

4 employees
AI, Biopharma
AFFIRMA BIOTECH SL vs

We develop new and selective treamtents for periodontitis.

Seed
8 employees
Biotechnology, Pharmaceutical
AFFIRMA BIOTECH SL vs

Pioneering breakthroughs in marine biochemistry to combat drug-resistant infections and advance the...

Seed
Biotechnology, Health Care

FAQ About AFFIRMA BIOTECH SL

Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections
AFFIRMA BIOTECH SL was founded in 2020.
AFFIRMA BIOTECH SL is headquartered in Spain.
AFFIRMA BIOTECH SL operates in Biopharma, Biotechnology, Life Sciences and Pharmaceutical. Its work centres on Drug development, Anti-infective drugs, Immunomodulation and Host-directed therapy.
AFFIRMA BIOTECH SL has approximately 5 employees.
AFFIRMA BIOTECH SL has completed 2 funding rounds, raising a total of $1.98M. The latest funding stage is Venture round.
Top alternatives and competitors to AFFIRMA BIOTECH SL include DevsHealth, PerioTrap Pharmaceuticals GmbH, Sealife PHARMA® GMBH, Altay Therapeutics, EOLO PHARMA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AFFIRMA BIOTECH SL and DevsHealth are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AFFIRMA BIOTECH SL, https://bouncewatch.com/company/affirma-biotech-sl, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout